Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response

Bibliographic Details
Main Authors: Yeo, Winnie, Chan, Stephen L, Mo, Frankie KF, Chu, Cheuk M, Hui, Joyce WY, Tong, Joanne HM, Chan, Anthony WH, Koh, Jane, Hui, Edwin P, Loong, Herbert, Lee, Kirsty, Li, Leung, Ma, Brigette, To, Ka F, Yu, Simon CH
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434865/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434865/

Similar Items